Agios Pharmaceuticals AGIO Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's preferred stock, shares authorized?
- Agios Pharmaceuticals (AGIO) reported preferred stock, shares authorized of $25M in Q1 2026.
- How has Agios Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- Agios Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $25M to $25M.
- What is the long-term trend for Agios Pharmaceuticals's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $25M to $25M.